Education
About Us
Working with TipRanks
Follow Us
Sienna Biopharmaceuticals Inc. (SNNAQ)
:SNNAQ
Total Valuation
Sienna Biopharmaceuticals has a market cap or net worth of $31.00. The enterprise value is $0.00.
Market Cap$31.00
Enterprise Value$0.00
Share Statistics
Sienna Biopharmaceuticals has 30,908,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,908,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sienna Biopharmaceuticals’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count13
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sienna Biopharmaceuticals is 0.00. Sienna Biopharmaceuticals’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, Sienna Biopharmaceuticals had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -54.63M and capital expenditures -10.00K, giving a free cash flow of -54.64M billion.
Operating Cash Flow-54.63M
Free Cash Flow-54.64M
Free Cash Flow per Share-1.77
Dividends & Yields
Sienna Biopharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.13
52-Week Price Change―
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Sienna Biopharmaceuticals upcoming earnings date is Oct 9, 2020, TBA Not Confirmed.
Last Earnings DateMay 8, 2019
Next Earnings DateOct 9, 2020
Ex-Dividend Date―
Financial Position
Sienna Biopharmaceuticals as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Sienna Biopharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sienna Biopharmaceuticals EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Sienna Biopharmaceuticals has $11.33M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$11.33M billion.
Cash & Marketable Securities$11.33M
Total Debt$0.00
Net Cash-$11.33M
Net Cash Per Share-$0.37
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Sienna Biopharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―